Skip to main content
ateles
.news
← All events
Entity
MAK Capital
1 event
Activist fund MAK Capital urged German biotech firm Evotec SE to list its US unit, valued at over €1 billion, and accelerate cost cutting following an 85% share price decline over five years.
Markets
Germany
United States
Unverified
3d ago